PSD502 in Subjects With Premature Ejaculation

Summary

This study is being done to test the effect of PSD502 (the study medication) compared to placebo in subjects with premature ejaculation. PSD502 is a topical (applied to skin) anesthetic spray containing a mixture of two drugs called lidocaine and prilocaine that will be applied to the penis. Half of the subjects will receive PSD502 and half will receive placebo.

Timeline

Start

2018-12-26

Primary completion

2021-05-04

Completion

2021-12-01

Drugs

Indications